SINTX Technologies, Inc. , an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications announced the closing of its previously announced registered direct offering of 1,500,000 shares of its common stock at a purchase price of $2.00 per share for gross proceeds of $3,000,000 priced at-the-market under Nasdaq rules.
The shares of common stock were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-230492) previously filed and declared effective by the Securities and Exchange Commission (SEC) on April 5, 2019. The offering of the shares of common stock was made by means of prospectus supplements that were filed with the SEC and form a part of the registration statement.
Maxim Group LLC acted as the sole placement agent for the offering. SINTX intends to use the net proceeds from the offerings for general working capital and general corporate purposes.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. A prospectus supplement relating to the shares of common stock was filed by SINTX with the SEC. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying prospectus, can be obtained at the SEC’s website at www.sec.gov or from Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174, Attention: Syndicate Department, or via email at syndicate@maximgrp.com or telephone at (212) 895-3745.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company manufactures silicon nitride material and components in its FDA registered and ISO 13485 certified facility.
Contact:
SINTX Technologies
801.839.3502
IR@sintx.com
Contact Information:
SINTX Technologies
801.839.3502
IR@sintx.com
Tags:
, Wire, Disclosure Newswire, United States, English
Contact Information:
SINTX Technologies
801.839.3502
IR@sintx.com